BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23243206)

  • 1. Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1.
    Lauden L; Boukouaci W; Borlado LR; López IP; Sepúlveda P; Tamouza R; Charron D; Al-Daccak R
    Circ Res; 2013 Feb; 112(3):451-64. PubMed ID: 23243206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence.
    Boukouaci W; Lauden L; Siewiera J; Dam N; Hocine HR; Khaznadar Z; Tamouza R; Borlado LR; Charron D; Jabrane-Ferrat N; Al-Daccak R
    Cardiovasc Res; 2014 Nov; 104(2):290-302. PubMed ID: 25213554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of allogenic T-cell cytotoxicity by hepatic stellate cell via CD4⁺ CD25⁺ Foxp3⁺ regulatory T cells in vitro.
    Wu TJ; Wang YC; Wu TH; Lee CF; Chan KM; Lee WC
    Transplant Proc; 2012 May; 44(4):1055-9. PubMed ID: 22564624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a human Th1-like IFNγ-secreting Treg subtype deriving from effector T cells.
    Venigalla RK; Guttikonda PJ; Eckstein V; Ho AD; Sertel S; Lorenz HM; Tretter T
    J Autoimmun; 2012 Dec; 39(4):377-87. PubMed ID: 22824211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulation and allogenicity in cardiac stem cell regenerative therapy.
    Charron D; Al-Daccak R
    Clin Transpl; 2013; ():249-55. PubMed ID: 25095515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
    Li W; Wang X; Chen R; Zhu H; Chen G; Sun X
    J Surg Res; 2012 Aug; 176(2):e79-87. PubMed ID: 22381170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
    Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
    Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human PD-L1-overexpressing porcine vascular endothelial cells induce functionally suppressive human CD4+CD25hiFoxp3+ Treg cells.
    Ding Q; Lu L; Zhou X; Zhou Y; Chou KY
    J Leukoc Biol; 2011 Jul; 90(1):77-86. PubMed ID: 21498584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation.
    Norde WJ; Maas F; Hobo W; Korman A; Quigley M; Kester MG; Hebeda K; Falkenburg JH; Schaap N; de Witte TM; van der Voort R; Dolstra H
    Cancer Res; 2011 Aug; 71(15):5111-22. PubMed ID: 21659460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.
    Sugimoto A; Suzuki M; Otani T; Okochi A; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2009 Dec; 37(12):1454-63. PubMed ID: 19819295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells.
    Jin X; Wang Y; Hawthorne WJ; Hu M; Yi S; O'Connell P
    Transplantation; 2014 Jan; 97(1):30-8. PubMed ID: 24092378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10.
    Bedke T; Pretsch L; Karakhanova S; Enk AH; Mahnke K
    J Immunol; 2010 May; 184(10):5562-70. PubMed ID: 20382886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism.
    Sugita S; Usui Y; Horie S; Futagami Y; Yamada Y; Ma J; Kezuka T; Hamada H; Usui T; Mochizuki M; Yamagami S
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):263-72. PubMed ID: 18775867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells.
    Dumitriu IE; Dunbar DR; Howie SE; Sethi T; Gregory CD
    J Immunol; 2009 Mar; 182(5):2795-807. PubMed ID: 19234174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
    Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
    J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.
    Taylor AL; Llewelyn MJ
    J Immunol; 2010 Dec; 185(11):6591-8. PubMed ID: 21048104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.